Summary: The New York Times publishes an investigative article exploring the impact of PTSD and moral injury in Veterans, highlighting published data from MAPS-sponsored clinical trials of MDMA-assisted therapy for PTSD in contrast to other PTSD treatments that are currently available to people suffering from the long-term effects of traumatic experiences. “We currently deal with PTSD as something that needs to be managed in an ongoing way, but this approach represents real hope for long-term healing,” says Rachel Yehuda, Ph.D., of the Icahn School of Medicine at Mount Sinai in New York.
The New York Times: A Balm for Psyches Scarred by War
